doi:10.1016/j.virs.2024.08.008

[1]
Lielian Zuo, Wenxin Yue, Shujuan Du, Shuyu Xin, Jing Zhang, Lingzhi Liu, Guiyuan Li, Jianhong Lu, 2017: An update: Epstein-Barr virus and immune evasion via microRNA regulation, Virologica Sinica, 32, 175-187. doi: 10.1007/s12250-017-3996-5
[2]
Ruikun Du, Qinghua Cui, Lijun Rong, 2021: Flu Universal Vaccines: New Tricks on an Old Virus, Virologica Sinica, 36, 13-24. doi: 10.1007/s12250-020-00283-6
[3]
Lin Cheng, Liuqing Yang, Miao Wang, Yabo Peng, Haiyan Wang, Xiaoxiang Yang, Juanjuan Zhao, Mingxia Zhang, Fuxiang Wang, Zheng Zhang, 2024: Isolation and characterization of mpox virus from the first mpox case in Shenzhen, China, Virologica Sinica, 39, 335-337. doi: 10.1016/j.virs.2024.01.004
[4]
Hong-bo FAN, Jun-wei LI, Zhi-lin LI, Wei ZHENG, Po Tien, De-yin GUO, 2007: Cloning of M and NP Gene of H5N1 Avian Influenza Virus and Immune Efficacy of their DNA Vaccines, Virologica Sinica, 22, 46-52.
[5]
Shaohong Chen, Xinghai Zhang, Yanfeng Yao, Shengdong Wang, Kangyin Li, Baoyue Zhang, Tianxi Ye, Li Chen, Yan Wu, Entao Li, Bichao Xu, Pei Zhang, Xia Chuai, Yong Ran, Rui Gong, Huajun Zhang, Sandra Chiu, 2024: Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters, Virologica Sinica, 39, 909-916. doi: 10.1016/j.virs.2024.09.005
[6]
Xianmiao Ye, Junnan Lu, Zirong Han, Zhishan Fan, Xinru Hu, Lichuang Jiao, Lisha Deng, Wenming Liu, Junqi Liu, Weiqi Pan, Ling Chen, Liqiang Feng, Caijun Sun, 2026: A semi-replicating VSV (srVSV)-based platform for developing broad-spectrum mucosal vaccines against influenza A viruses, Virologica Sinica, 41, 423-438. doi: 10.1016/j.virs.2026.04.004
[7]
Wei Ye, Yangchao Dong, He Liu, Hongwei Ma, Yingfeng Lei, Fanglin Zhang, 2026: Hijacking the host heparan sulfate-cell-surface ribonucleoproteins (RNPs) scaffold pathway for viral immune evasion, Virologica Sinica, 41, 999-1001. doi: 10.1016/j.virs.2026.06.006
[8]
Tiandan Xiang, Junzhong Wang, Xin Zheng, 2022: The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages, Virologica Sinica, 37, 786-795. doi: 10.1016/j.virs.2022.11.007
[9]
Jieliang Chen, Zhenghong Yuan, 2014: Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies, Virologica Sinica, 29, 17-24. doi: 10.1007/s12250-014-3412-3
[10]
Xincheng Ni, Kai Wang, Yinze Han, Jian Lei, 2024: Structural analysis of conformational changes in the mpox virus A7 protein, Virologica Sinica, 39, 331-334. doi: 10.1016/j.virs.2023.12.006
[11]
Ahmed H. Ghonaim, Sherin R. Rouby, Wedad M. Nageeb, Ashraf Ahmed Elgendy, Rong Xu, Changsheng Jiang, Noha H. Ghonaim, Qigai He, Wentao Li, 2025: Insights into recent advancements in human and animal rotavirus vaccines: Exploring new frontiers, Virologica Sinica, 40, 1-14. doi: 10.1016/j.virs.2024.12.001
[12]
Lei Yu, Yingfen Wen, Mengrong Xiang, Wenxin Hong, Lingzhai Zhao, Fuchun Zhang, 2020: The Limitation of Rapid Tests for DENV2 Infection in Host with Unique Immune Status: Low NS Antigenemia and Deficient Antibody Responses, Virologica Sinica, 35, 478-480. doi: 10.1007/s12250-019-00183-4
[13]
Weizhi Lu, Linjuan Shi, Jing Gao, Huimin Zhu, Ying Hua, Jintai Cai, Xianbo Wu, Chengsong Wan, Wei Zhao, Zhang Bao, 2021: Piperlongumine Inhibits Zika Virus Replication In vitro and Promotes Up-Regulation of HO-1 Expression, Suggesting An Implication of Oxidative Stress, Virologica Sinica, 36, 510-520. doi: 10.1007/s12250-020-00310-6
[14]
Chen Yang, Runchu Zhao, Shuting Huo, Yaqing Zhang, Jingxi Feng, Mingli Gong, Lin Zhu, Conggang Zhang, Linqi Zhang, Jing Xue, Rong Zhang, Qihui Wang, Qiang Ding, 2026: Bruton's tyrosine kinase inhibitor BTKi-2 inhibits mpox virus and vaccinia virus infection, Virologica Sinica, 41, 700-710. doi: 10.1016/j.virs.2026.06.011
[15]
Shuoxuan Zhao, Yichao Chen, Tianxin Zhang, Yaoyao Gao, Jing Wu, Fangji Yang, Yongxiang Liu, Xuesong Liu, Nan Qi, 2026: Degradation of ACSL3 by influenza A virus shifts unfolded protein response from antiviral defense to viral evasion, Virologica Sinica, 41, 638-650. doi: 10.1016/j.virs.2026.06.008
[16]
Mingxiao Ma, 2014: New insights of Sacbrood virus, Virologica Sinica, 29, 410-413. doi: 10.1007/s12250-014-3540-9
[17]
Ma-ping Deng, Zhi-hong Hu, Hua lin, Deng Wang Fei, 2012: Developments of Subunit and VLP Vaccines Against Influenza A Virus^*, Virologica Sinica, 27, 145-153. doi: 10.1007/s12250-012-3241-1
[18]
马相如, 胡勤芹, 肖少波, 方六荣, 陈焕春*, 2004: Cloning and Sequence Analysis of the Genome Unique Long Region of Pseudorabies Virus Ea Strain, Virologica Sinica, 19, 120-124.
[19]
Jianjian Li, Lin Li, Shaomin Yang, Jingyun Li, Mi Zhang, Cuixian Yang, Jiafa Liu, Huiqin Li, 2016: Identification and characterization of two human immunodeficiency virus type 1 unique recombinant forms from Yunnan, China, Virologica Sinica, 31, 184-187. doi: 10.1007/s12250-015-3671-7
[20]
Ahmed H. Ghonaim, Sherin R. Rouby, Wedad M. Nageeb, Ashraf Ahmed Elgendy, Rong Xu, Changsheng Jiang, Noha H. Ghonaim, Qigai He, Wentao Li, 2025: Corrigendum to “Insights into recent advancements in human and animal rotavirus vaccines: Exploring new frontiers” [Virol. Sin. 40 (2025) 1-14], Virologica Sinica, 40, 1066-1067. doi: 10.1016/j.virs.2025.10.002